BioReference Laboratories
Opko Health, BioReference Health Settle Charges of Lab Fraud
The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.
Labcorp to Acquire Select Assets of BioReference Health for $237.5M
Under the deal, Labcorp will acquire BioReference's laboratory testing businesses focused on clinical diagnostics and reproductive and women's health in certain states.
Earnings Roundup: OraSure Technologies, Opko Health, Biodesix, Sophia Genetics,
OraSure, Opko, Sophia Genetics, and Biodesix reported their third quarter financial results this week.
In Brief This Week: PerkinElmer, CDC, Opko, DermTech, OpGen, More
News items for the week of May 1, 2023.
In Brief This Week: Abbott, Thermo Fisher Scientific, Danaher, Oncocyte, Biocartis, More
News items for the week of Feb. 20, 2023.
Dec 21, 2022
Oct 20, 2022
Aug 31, 2022
Oct 28, 2021
Opko Health Q3 Revenues Fall 10 Percent
Sep 2, 2021
May 6, 2021
Apr 29, 2021